May 7, 2018 / 8:16 PM / 4 months ago

BRIEF-Mirati Therapeutics Reports Q1 Loss Per Share $0.51

May 7 (Reuters) - Mirati Therapeutics Inc:

* MIRATI THERAPEUTICS REPORTS FIRST QUARTER FINANCIAL RESULTS

* Q1 LOSS PER SHARE $0.51

* Q1 EARNINGS PER SHARE VIEW $-0.60 — THOMSON REUTERS I/B/E/S

* QTRLY TOTAL REVENUE $9.5 MILLION

* ON TRACK TO FILE PLANNED INDA FOR MRTX849, A POTENT AND SELECTIVE INHIBITOR FOR KRAS, IN Q4 OF 2018 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below